Seer, Inc. (NASDAQ:SEER) Short Interest Update

Posted by on Sep 30th, 2026

Seer, Inc. (NASDAQ:SEER – Get Free Report) was the target of a large drop in short interest in September. As of September 15th, there was short interest totaling 87,329 shares, a drop of 40.1% from the August 31st total of 145,773 shares. Based on an average daily volume of 157,532 shares, the short-interest ratio is currently 0.6 days. Approximately 0.2% of the shares of the stock are short sold.

Wall Street Analysts Forecast Growth

Separately, Weiss Ratings reiterated a “sell (d-)” rating on shares of Seer in a report on Friday, July 17th. Two analysts have rated the stock with a Strong Buy rating and one has assigned a Sell rating to the company’s stock. Based on data from MarketBeat.com, the stock has an average rating of “Buy” and an average price target of $4.00.

View Our Latest Stock Report on SEER

Seer Stock Up 0.2%

Shares of NASDAQ:SEER opened at $2.15 on Wednesday. The firm has a 50-day simple moving average of $2.02 and a 200 day simple moving average of $1.90. Seer has a fifty-two week low of $1.55 and a fifty-two week high of $2.41. The company has a market cap of $119.33 million, a PE ratio of -1.77 and a beta of 1.50.

Seer (NASDAQ:SEER – Get Free Report) last issued its quarterly earnings data on Tuesday, August 11th. The company reported ($0.31) earnings per share for the quarter, missing the consensus estimate of ($0.27) by ($0.04). The firm had revenue of $3.10 million during the quarter, compared to the consensus estimate of $3.55 million. Seer had a negative net margin of 478.05% and a negative return on equity of 27.23%.

Hedge Funds Weigh In On Seer

Several institutional investors and hedge funds have recently bought and sold shares of SEER. Corient Private Wealth LP grew its stake in shares of Seer by 15.8% in the 2nd quarter. Corient Private Wealth LP now owns 73,200 shares of the company’s stock valued at $122,000 after buying an additional 10,000 shares in the last quarter. Marquette Asset Management LLC acquired a new position in Seer in the 2nd quarter valued at $103,000. NewEdge Advisors LLC bought a new stake in Seer during the first quarter valued at about $132,000. Rangeley Capital LLC boosted its position in shares of Seer by 821.5% in the first quarter. Rangeley Capital LLC now owns 184,302 shares of the company’s stock valued at $310,000 after acquiring an additional 164,302 shares during the period. Finally, T3 Companies LLC bought a new position in shares of Seer during the 4th quarter worth about $242,000. Hedge funds and other institutional investors own 75.20% of the company’s stock.

About Seer

(Get Free Report)

Seer, Inc is a life sciences technology company that develops tools for large-scale protein analysis, or proteomics. Its platform is designed to help researchers study the proteins present in biological samples, supporting applications in drug discovery, biomarker research, translational research and the development of precision medicine.

The company’s principal offering is the Proteograph Product Suite, which uses proprietary nanoparticle technology to provide broad and rapid access to the proteome.

Read More

Receive News & Ratings for Seer Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Seer and related companies with MarketBeat.com's FREE daily email newsletter.